Cargando…
The ROX index: “Propelled” by high-flow nasal cannula therapy during the COVID-19 pandemic into greater applicability in respiratory support
Autores principales: | Melo-Diaz, Lucélia Luna, Kieling, George Alvicio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Canadian Society of Respiratory Therapists
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680963/ https://www.ncbi.nlm.nih.gov/pubmed/36506639 http://dx.doi.org/10.29390/cjrt-2022-012 |
Ejemplares similares
-
Effectiveness of high-flow nasal cannula therapy on clinical outcomes in adults with COVID-19: A systematic review
por: Arruda, Daiana Gonçalves, et al.
Publicado: (2023) -
Predicting Outcomes of High-Flow Nasal Cannula for Acute Respiratory Distress Syndrome. An Index that ROX
por: Hill, Nicholas S., et al.
Publicado: (2019) -
The Relationship of Respiratory Rate-Oxygenation (ROX) and Modified ROX Index With High-Flow Nasal Cannula Oxygen Therapy in COVID-19 Patients: An Observational Pilot Study
por: Karim, Habib Md R, et al.
Publicado: (2022) -
Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure
por: Lemiale, Virginie, et al.
Publicado: (2021) -
Correction to: Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure
por: Lemiale, Virginie, et al.
Publicado: (2021)